Abe, Mizuki Tokushima University
Murakami, Keiji Tokushima University|Kawasaki University of Medical Welfare Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Hiroshima, Yuka Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Sebe, Mayu Kawasaki University of Medical Welfare
Kataoka, Keiko Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Fujii, Hideki Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Macrolide antibiotics are used in treating Pseudomonas aeruginosa chronic biofilm infections despite their unsatisfactory antibacterial activity, because they display several special activities, such as modulation of the bacterial quorum sensing and immunomodulatory effects on the host. In this study, we investigated the effects of the newly synthesized P. aeruginosa quorum-sensing autoinducer analogs (AIA-1, -2) on the activity of azithromycin and clarithromycin against P. aeruginosa. In the killing assay of planktonic cells, AIA-1 and -2 enhanced the bactericidal ability of macrolides against P. aeruginosa PAO1; however, they did not affect the minimum inhibitory concentrations of macrolides. In addition, AIA-1 and -2 considerably improved the killing activity of azithromycin and clarithromycin in biofilm cells. The results indicated that AIA-1 and -2 could affect antibiotic tolerance. Moreover, the results of hydrocarbon adherence and cell membrane permeability assays suggested that AIA-1 and -2 changed bacterial cell surface hydrophobicity and accelerated the outer membrane permeability of the hydrophobic antibiotics such as azithromycin and clarithromycin. Our study demonstrated that the new combination therapy of macrolides and AIA-1 and -2 may improve the therapeutic efficacy of macrolides in the treatment of chronic P. aeruginosa biofilm infections.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
|DOI (Published Version)|
|URL ( Publisher's Version )|
anti_11_1_10.pdf 13 MB
Institute of Advanced Medical Sciences